BIOLIFE SOLUTIONS INC (BLFS)
Health Care / Health Care Supplies
S&P SmallCap 600$19.27
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 4 of 5 models — moderate confidence
Is BIOLIFE SOLUTIONS INC a Good Investment in 2026?
BIOLIFE SOLUTIONS INC (BLFS) scores 2.4 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates BIOLIFE SOLUTIONS INC as Attractive (6/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 94%). BIOLIFE SOLUTIONS INC ranks #1068 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 94%)
Frequently Asked Questions
Is BIOLIFE SOLUTIONS INC (BLFS) a good investment?
What is BIOLIFE SOLUTIONS INC's Piotroski F-Score?
Is BLFS overvalued or undervalued?
How does BLFS compare to other Health Care stocks?
What do investment models say about BLFS?
Similar Stocks
Compare BLFS with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer